Q98407053

Summary

Q98407053 is a report^[1].

Key Facts

• Q98407053's instance of is recorded as report^[2].
• Q98407053's part of the series is recorded as reports of the 2015/16 legislative session of the Riksdag^[3].
• Q98407053's language of work or name is recorded as Swedish^[4].
• Q98407053 was released on +2016-05-27T00:00:00Z^[5].
• Q98407053's significant event is recorded as debate^[6].
• Q98407053's main subject is medication^[7].
• Q98407053's work available at URL is recorded as http://data.riksdagen.se/dokument/H301SoU13^[8].
• Q98407053's work available at URL is recorded as http://data.riksdagen.se/dokumentstatus/H301SoU13^[9].
• Q98407053's work available at URL is recorded as http://data.riksdagen.se/fil/95244EBD-CC89-44F0-B6B5-440E923ACB30^[10].
• Q98407053's applies to jurisdiction is recorded as Sweden^[11].
• Q98407053's legal citation of this text is recorded as bet. 2015/16:SoU13^[12].
• Q98407053's title is recorded as Uppföljning av smittskyddsläkemedel^[13].
• Q98407053's has immediate cause is recorded as Q97767613^[14].
• Q98407053's has immediate cause is recorded as Q98121259^[15].
• Q98407053's maintained by WikiProject is recorded as Project Riksdagen's documents^[16].
• Q98407053's copyright status is recorded as public domain^[17].
• Q98407053's legislative committee is recorded as Committee on Health and Welfare^[18].

Body

Definition and Type

Q98407053's instance of is recorded as report^[2].